Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460746
Status:
COMPLETED
Last Update Posted:
2013-07-31
First Post:
2007-04-13
Brief Title:
EnfuvirtideCurrent Protease Inhibitor Switch to PREZISTA DarunavirRitonavir TMC125 in HIV Patients With Enfuvirtide Side Effects
Sponsor:
Tibotec Inc
Organization:
Tibotec Inc
Organization Data
Organization:
Tibotec Inc
Class:
INDUSTRY
Study ID:
CR011866
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tibotec Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Tibotec Therapeutics a Division of Ortho Biotech Products LP USA | INDUSTRY |